227 related articles for article (PubMed ID: 19820906)
21. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
23. [Downstaging of esophageal carcinoma after preoperative radio- and chemotherapy].
Staar S
Strahlenther Onkol; 1996 Dec; 172(12):693-5. PubMed ID: 8992641
[No Abstract] [Full Text] [Related]
24. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
25. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
26. Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.
Blum Murphy MA; Elimova E; Ajani JA
Expert Rev Gastroenterol Hepatol; 2016; 10(3):383-92. PubMed ID: 26560689
[TBL] [Abstract][Full Text] [Related]
27. Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction Cancers.
Ku GY
Surg Oncol Clin N Am; 2017 Apr; 26(2):241-256. PubMed ID: 28279467
[TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant therapy in the upper gastro-intestinal tract. Gastric cancer from a surgical viewpoint].
Ott K; Lordick F
Chirurg; 2009 Nov; 80(11):1028-34. PubMed ID: 19756431
[TBL] [Abstract][Full Text] [Related]
29. Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomas.
Wang J; Milton DR; He L; Komaki R; Liao Z; Crane CH; Minsky BD; Thall PF; Lin SH
J Thorac Oncol; 2015 Mar; 10(3):518-26. PubMed ID: 25695222
[TBL] [Abstract][Full Text] [Related]
30. [Gastric cancer and adenocarcinoma of the esophagogastric junction: principles of neoadjuvant therapy].
Lordick F; Ott K; Sendler A
Chirurg; 2011 Nov; 82(11):968-73. PubMed ID: 22002702
[TBL] [Abstract][Full Text] [Related]
31. Therapy for esophageal cancer.
Heath EI; Forastiere AA
Cancer Treat Res; 2001; 105():387-98. PubMed ID: 11224996
[No Abstract] [Full Text] [Related]
32. Role of chemotherapy in the treatment of gastroesophageal cancers.
Hwang JJ
Oncology (Williston Park); 2007 Apr; 21(5):579-86; discussion 587, 591-2. PubMed ID: 17536343
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
34. Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02).
Ruhstaller T; Templeton A; Ribi K; Schuller JC; Borner M; Thierstein S; von Moos R; Pederiva S; Lohri A; Lombriser N; von Briel C; Koeberle D; Popescu R
Onkologie; 2010; 33(5):222-8. PubMed ID: 20502056
[TBL] [Abstract][Full Text] [Related]
35. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
36. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
[TBL] [Abstract][Full Text] [Related]
37. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
38. [Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study].
Lordick F; Siewert JR
Chirurg; 2006 Dec; 77(12):1166-7. PubMed ID: 17091285
[No Abstract] [Full Text] [Related]
39. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
Chua YJ; Cunningham D
Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
[No Abstract] [Full Text] [Related]
40. [Multimodality therapy concepts in esophageal carcinoma].
Siewert JR; Ott K
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():39-43. PubMed ID: 11824282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
